Topic-Driven Round Table on DCIS: Endocrine Therapy
Facilitator Deb Hackenberry is joined by Dr. Deanna Attai, breast surgeon at UCLA Health, to discuss Endocrine Therapy as it pertains to DCIS.
Topic-Driven Round Table on DCIS: Health Literacy
Women with DCIS joined facilitator Deb Hackenberry and others via video or phone to learn about and discuss “Health Literacy” as it pertains to DCIS.
Topic-Driven Round Table on Lobular Breast Cancer
Join seasoned lobular breast cancer advocates Leigh Pate,Lobular Breast Cancer Alliance co-coordinator, and Elizabeth Viggiano to discuss your concerns and questions about lobular breast cancer and the role of advocacy to advance research and educate. *This is a Round Table program, but took place via webinar.* https://www.youtube.com/watch?v=pzB9OcoGy0E
Navigating Your Ovarian Cancer Pathology Report
Do you wish you could better understand your pathology report? This report provides information about your tumor tissue and is used for diagnosis and treatment decisions. Dr. Tamara Kalir, Professor of Pathology at Icahn School of Medicine at Mt. Sinai, will help us better understand the pathology of ovarian cancer, clarify what goes into a […]
Lobular Breast Cancer: Understanding this Subtype and its Treatment
Dr. Otto Metzger, oncologist at Dana Farber Cancer Institute, discusses treatment for lobular breast cancer. He will also talk about his own research on identifying predictive biomarkers of sensitivity when it comes to endocrine therapy. Dr. Metzger will also be joined by patient advocate Lori Petitti of the Lobular Breast Cancer Alliance. https://www.youtube.com/watch?v=SvgEnfMAgpE
The Changing Role of PARP Inhibitors in the Treatment of Ovarian Cancer
In recent years, researchers have been looking into using a class of drugs called PARP inhibitors to prevent the progression and recurrence of ovarian cancer. Dr. Kathleen Moore of Stephenson Cancer Center, Principal Investigator of the SOLO-1 trial, explains how the results of this trial may affect ovarian cancer patients and where research on ovarian […]
Understanding and Treating HER2+ Breast Cancer
Dr. Rena Callahan, a hematologist-oncologist of the Ronald Reagan UCLA Medical Center and Assistant Clinical Professor of Medicine at the David Geffen School of Medicine at UCLA, discusses HER2+ breast cancer, its current treatment, and possible treatment advances. This webinar took place on December 3, 2018. https://www.youtube.com/watch?v=QyX0CTFQsK4
Understanding Genetic Counseling
Rania Sheikh, MS, a certified genetic counselor from Memorial Sloan Kettering Cancer Center, provides an overview of the role of a genetic counselor in cancer diagnosing and treatment. Further, she explains how women can access counselors and how genetics can impact treatment options. https://www.youtube.com/watch?v=ec2Sf9zYUuU
Less Pain, More Gain: Palliative Care for Ovarian Cancer
Joann Guerilus In this webinar, Dr. Carolyn Lefkowits of CU Denver leads a presentation on palliative care and what it means for those with recurrent ovarian cancer. https://vimeo.com/236807928
